share_log

Thermo Fisher Scientific | 8-K: Current report

Thermo Fisher Scientific | 8-K: Current report

賽默飛世爾 | 8-K:重大事件
美股SEC公告 ·  2024/07/11 04:40

Moomoo AI 已提取核心訊息

Thermo Fisher Scientific announced on July 10, 2024, the expiration and results of its tender offer for Olink Holding AB through its wholly owned subsidiary Orion Acquisition AB. The tender offer aimed to acquire all outstanding common shares and American Depositary Receipts of Olink Holding AB, with each ADR representing one common share.The announcement was made via a press release, which was filed as an exhibit to the company's Schedule TO-T/A with the Securities and Exchange Commission. Senior Vice President and General Counsel Michael A. Boxer signed the filing on behalf of Thermo Fisher Scientific.
Thermo Fisher Scientific announced on July 10, 2024, the expiration and results of its tender offer for Olink Holding AB through its wholly owned subsidiary Orion Acquisition AB. The tender offer aimed to acquire all outstanding common shares and American Depositary Receipts of Olink Holding AB, with each ADR representing one common share.The announcement was made via a press release, which was filed as an exhibit to the company's Schedule TO-T/A with the Securities and Exchange Commission. Senior Vice President and General Counsel Michael A. Boxer signed the filing on behalf of Thermo Fisher Scientific.
賽默飛世爾於2024年7月10日宣佈,Olink Holding Ab的收購要約通過其全資子公司Orion Acquisition Ab到期並公佈結果。該收購要約旨在收購Olink Holding Ab所有未償還的普通股和美國存託憑證,每份ADR代表一股普通股。該公告通過新聞稿發佈,並作爲附錄提交給證券交易委員會的公司TO-T/A表格。賽默飛世爾的高級副總裁兼總法律顧問Michael A. Boxer代表公司簽署了該文件。
賽默飛世爾於2024年7月10日宣佈,Olink Holding Ab的收購要約通過其全資子公司Orion Acquisition Ab到期並公佈結果。該收購要約旨在收購Olink Holding Ab所有未償還的普通股和美國存託憑證,每份ADR代表一股普通股。該公告通過新聞稿發佈,並作爲附錄提交給證券交易委員會的公司TO-T/A表格。賽默飛世爾的高級副總裁兼總法律顧問Michael A. Boxer代表公司簽署了該文件。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息